The World Health Organization (WHO) on the 9th, as the global medical serum shortage of supply, the developing countries that need it most and also serious shortages in remote areas, the international community on the treatment of the wounded and rescue capability not ideal. To solve this problem, on the 10th, WHO convened a special meeting, inviting medical experts, donors and recipient representatives, pharmaceutical companies and relevant international organizations to jointly work out as soon as possible to improve the situation of the action plan.
WHO said that at present, the global average annual 12 million people bitten by an animal or sting injury, the shortage of medical use of serum to the lives of these victims were under serious threat. Due to various reasons, serum developed for medical use, output is declining, serum production in developing countries is very limited. WHO that priority is to improve the capacity of developing countries serum, serum remote areas to improve the supply situation.
To this end, the organization called on developed countries to actively transfer of technology to developing countries, and the delivery of serum solve problems, in particular to ensure their preservation and refrigerated transport. WHO also urged developing countries to strengthen medical personnel, especially in remote areas of professional training of health workers, to enhance their knowledge of the relevant.
According to WHO statistics, the threat of rabies, the first ten biggest killer, if not for timely treatment, the mortality rate is 100%, but after contact with the rabies virus, as long as the medical use of serum, preventive is 100%. WHO estimates that about 8 million annually from contact with people suspected of animals with rabies virus in need of medical care with serum, which is nearly half of the children under the age of 15, contracted rabies and 99% of all people living in Africa and Asia.
In addition, the annual global Nearly 5 million people were bitten by snakes or scorpions sting injuries, of which 50% to 75% of the victims in need of medical care with the serum in order to avoid amputation, serious neurological disorders or death. WHO said, for the treatment of snakebites or scorpion sting injury, the world needs at least annually 10 million antitoxic serum, the only requirement Africa reached two million.
Currently, WHO is developing a five-year plan aimed at promoting the international market for medical use serum production and distribution of the relevant authorities to help predict market demand for the serum to strengthen their related management capabilities. |